AstraZeneca Acquires Chinese Generics Maker, Guangdong BeiKang Pharma

AstraZeneca announced it has entered into an agreement to acquire Guangdong BeiKang Pharmaceutical, a privately-owned generics manufacturing company, based in Conghua City, Guangdong province, China.
Asian Scientist